Introduction
============

Nanoparticles are used in biomedical applications such as therapeutics, catalysis, antimicrobial agents, transfection vectors, biosensing devices, and fluorescent labels.[@b1-ijn-10-7057]--[@b5-ijn-10-7057] Silver nanoparticles (AgNPs), as one of the most commonly used metal nanoparticles, have recently gained popularity. AgNPs, with a broad antibacterial activity against both gram-negative and gram-positive microorganisms, has been employed for antimicrobial properties, and thus they are involved in the production of several medical products like catheters or implants[@b6-ijn-10-7057] and are also used for their antifungal,[@b7-ijn-10-7057] antiangiogenic,[@b8-ijn-10-7057] and anticancer properties.[@b9-ijn-10-7057] Despite their potential benefits to society, biological adverse effects of AgNPs must be carefully evaluated. Several studies have demonstrated that AgNPs can enter into cells in fish, mice, and humans and be distributed throughout the body.[@b10-ijn-10-7057]--[@b13-ijn-10-7057] AgNPs can be systemically distributed throughout and may be accumulated and redistributed between various organs, leading to decreased body weight, changes in blood biochemical parameters, and inflammation.[@b14-ijn-10-7057]--[@b16-ijn-10-7057] Previous studies have indicated that AgNPs induce cytotoxicity via the generation of reactive oxygen species (ROS), leading to increases in intracellular oxidative stress or Jun amino-terminal kinases (JNK) activation, which leads to the release of cytochrome C into the cytosol and translocation of Bax into mitochondria.[@b17-ijn-10-7057],[@b18-ijn-10-7057] These releases induce cell apoptosis, autophagy, and necrosis.[@b19-ijn-10-7057],[@b20-ijn-10-7057] Previous studies have shown that AgNP-treated cells cause different cellular responses that may be important for their use in medicine and their toxicity.[@b20-ijn-10-7057]--[@b22-ijn-10-7057]

In mice, the cells migrate to the nascent gonads and proliferate at \~10.5--11.5 days postcoitum (dpc) and then migrate from the gonads to the testes or ovaries at 13.5 dpc.[@b23-ijn-10-7057],[@b24-ijn-10-7057] Female germ cells, or oogonia, stop dividing and enter meiosis prophase I at 13.5 dpc through the leptotene, zygotene, pachytene, and diplotene stages to become oocytes in ovaries and are finally arrested at the diplotene stage.[@b25-ijn-10-7057] Synaptonemal complex protein 3 (SCP3), synaptonemal complex protein 1 (SCP1), stimulated by retinoic acid 8 (Stra8), deleted in azoospermia-like (Dzal), and DNA meiotic recombinase 1 (Dmc1) are meiotic markers.[@b26-ijn-10-7057] In mice, retinoic acid, an extrinsic meiosis-initiating signal, induces the transcription and expression of Stra8, which in turn governs the meiotic program.[@b27-ijn-10-7057],[@b28-ijn-10-7057] Dazl, an intrinsic factor, is required for meiotic DNA replication and the subsequent events of meiotic prophase.[@b29-ijn-10-7057] SCP3 plays a critical role in pairing and recombination of homologous chromosomes in meiosis 1.[@b30-ijn-10-7057] Exposure to environmental factors in pregnant mice affects the expression of meiosis genes and meiotic progression.[@b31-ijn-10-7057],[@b32-ijn-10-7057]

The placenta is an important organ for material exchange between fetal and maternal blood and is the main source of nutrients for the fetus.[@b33-ijn-10-7057] Imprinted genes play important roles in placental differentiation, growth, and function, with profound effects on fetal development.[@b34-ijn-10-7057],[@b35-ijn-10-7057] It has been suggested that changes in imprinted gene dosage in the placentae may compromise the prenatal control of nutritional resources.[@b36-ijn-10-7057] Epigenetic events are crucial for early development but can be affected by environmental factors and diets.[@b37-ijn-10-7057],[@b38-ijn-10-7057] Gallou-Kabani et al[@b39-ijn-10-7057] showed that a high-fat diet during pregnancy modified the expression of imprinted genes and local and global DNA methylation patterns in the placenta, and global DNA methylation resulted in sex- and diet-specific differences. Martha et al[@b40-ijn-10-7057] demonstrated that bisphenol A (BPA) exposure may perturb fetal and postnatal health through epigenetic changes in the embryo and alterations in placental development. Abnormal expression of an imprinted gene will affect the development of the fetus, its health later in life, and the child's behavior.[@b41-ijn-10-7057],[@b42-ijn-10-7057] *Igf2* is a paternal allele gene and encodes a fetal growth factor; deletion of the *Igf2* gene caused a significant decrease in fetal and placental weight compared with a control group.[@b43-ijn-10-7057] Loss of function alleles on insulin-like growth factor 2 receptor (Igf2r) growth functions resulted in overgrowth of the embryo heart and placenta with partial perinatal lethality.[@b44-ijn-10-7057] In addition, low expression of H19 messenger RNA (mRNA) may contribute to the development of macrosomia.[@b45-ijn-10-7057] Exposure to AgNPs caused mitochondrial dysfunction, which leads to the induction of ROS, DNA damage, and chromosomal aberrations, apoptosis, and autophagy.[@b46-ijn-10-7057] AgNPs increased ROS production in cells, leading to apoptosis through the activation of p42/p44, JNKs, or p38 mitogen-activated protein kinases or p53-dependent processes.[@b47-ijn-10-7057],[@b48-ijn-10-7057]

Because of the extensive use of AgNPs in consumer products and increasing potential of human and environmental exposure, safety and regulatory concerns regarding AgNPs are growing.[@b49-ijn-10-7057],[@b50-ijn-10-7057] The primary objective of this study was to synthesize smaller AgNPs using biological systems. The secondary objective of this study was to investigate the effect of the smaller-size AgNPs on fetal development, including imprinted gene expression and on imprinted gene DNA methylated regions (DMRs) in fetuses during pregnancy. Finally, we investigated the effect of AgNPs on the expression of meiosis genes and meiosis progression during pregnancy.

Materials and methods
=====================

Materials
---------

Luria--Bertani agar was purchased from USB Corporation (Santa Clara, CA, USA). Mueller--Hinton broth and agar, silver nitrate, and crystal violet were purchased from Sigma-Aldrich (St Louis, MO, USA). All the other chemicals were purchased from Sigma-Aldrich unless otherwise stated.

Synthesis and characterization of AgNPs
---------------------------------------

Synthesis and characterization of AgNPs was carried out according to the method described earlier.[@b8-ijn-10-7057] Briefly, *Bacillus mycoides* strain was inoculated into flasks containing sterile Luria--Bertani broth and incubated for 24 hours at 37°C with agitation (200 rpm). After incubation, the culture was centrifuged at 10,000 rpm for 10 minutes, and the supernatant was used for AgNP synthesis. In a typical reaction, the culture supernatant was mixed with 5 mM aqueous AgNO~3~ solution (add 50 μL of 5 M aqueous AgNO~3~ solution in 50 mL culture supernatant, aqueous AgNO~3~ dissolved in deionized water to prepare aqueous AgNO~3~ solution) and incubated at 60°C for 6 hours in a water bath. This liquid was then centrifuged at 3,000 rpm for 10 minutes, the supernatant was the AgNPs solution. The as-prepared particles were characterized as previously described.[@b51-ijn-10-7057] X-ray diffraction (XRD) analyses were performed using an X-ray diffractometer (Bruker D8 DISCOVER; Bruker AXS GmBH, Karlsruhe, Germany). The high-resolution XRD measurements were performed at 3 kW with a Cu target using a scintillation counter (λ =1.5406 Å) at 40 kV and 40 mA and were recorded in the range of 2θ =5°--80°. Further characterization of the AgNPs surface changes and composition was performed using Fourier transform infrared (FT-IR) spectroscopy (Perkin Elmer Spectroscopy GX; Perkin Elmer, Waltham, MA, USA). Transmission electron microscopy (TEM; Hitachi H-7500, Seoul National University, Seoul, Republic of Korea) was used to determine the size and morphology of the AgNPs. TEM images of bio-AgNPs were obtained at an accelerating voltage of 300 kV.

Animals, treatment, and experimental design
-------------------------------------------

All the experiments were performed with approval from the Institutional Animal Care and Use Committee at Konkuk University (IACUC approval number KU11035), Seoul, Republic of Korea. Virgin, female, 8-week-old ICR (imprinting control region) mice were purchased for this study and were housed in temperature-controlled (21°C--22°C) and light-controlled (12-hour light, 12-hour dark cycle) environments with 70% humidity and fed under ad libitum conditions. The females were mated with male mice and inspected daily for a mating plug. At 0.5 dpc, vaginal plugs were detected. Each female was housed individually.

The mice were divided into two groups (20 mice in each group) as follows: group 1, control; group 2, 1.0 mg/kg AgNP-treated group. The control group received phosphate-buffered saline without AgNPs using the same method used to administer AgNPs suspensions; the 1.0 mg AgNPs/kg was administrated to the mice via intravenous infusion one time at 1.0 mg/kg doses at 6.5 dpc. At 13.5, 15.5, and 17.5 dpc, the pregnant mice were sacrificed through cervical dislocation euthanasia, and then embryo and placenta were isolated for further study.

Evaluation of oocyte meiotic prophase I stages
----------------------------------------------

The pregnant mice in the control and experimental groups were sacrificed with spinal dislocation death at 13.5 and 17.5 dpc, respectively, for collection of developing fetal oocytes. The meiotic status of the oocytes was confirmed by chromosome condition examination.[@b31-ijn-10-7057] The oocytes were treated in 1% sodium citrate for 20 minutes at room temperature, fixed in 4% paraformaldehyde, spread on polylysine-coated slides for 8 hours, blocked in tris-buffered saline with 1% donkey serum and 3% bovine serum albumin for 30 minutes at room temperature, and then incubated overnight at 4°C with SCP3 antibody (Novus, Littleton, CO, USA) at a dilution of 1:200. The next day, sections were incubated with Cy3-labeled goat anti-rabbit IgG at a dilution of 1:50 (Beyotime, Nantong, People's Republic of China) at 37°C for 1.5 hours, followed by incubation with Hoechst33342 at a dilution of 1:1,000 for 5 minutes at room temperature. The slides were analyzed under a fluorescence microscope (Olympus BX51; Olympus Corporation, Tokyo, Japan), and the meiotic prophase stages were determined based on the SCP3 immunostaining characteristic patterns within the germ cells.[@b32-ijn-10-7057]

Methylation studies
-------------------

DNA was isolated using a micro DNA isolation kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. One microgram of DNA was treated with sodium bisul-fate using a Methyl amp™ DNA modification kit (Epigentek, Farmingdale, NY, USA) according to the manufacturer's instructions. The bisulfite-treated DNA was subject to nested (seminested) polymerase chain reaction (PCR) amplification for pleiomorphic adenoma gene-like 1 (*Zac1*) and *Igf2r* (primer sequences are given in [Table 1](#t1-ijn-10-7057){ref-type="table"}). The PCR products were separated by electrophoresis on 1% agarose gel, and bands of appropriate size were isolated from the gel and purified with the Wizard SV Gel and PCR Clean-Up System (Promega, Madison, WI, USA). Purified DNA was cloned into a pGEM-T easy Vector (Promega) according to the manufacturer's instructions. Positive clones were obtained by antibiotic selection, and the insert was DNA sequenced.

RNA extraction and RT-PCR
-------------------------

Total RNA was prepared using the RNeasy Mini Kit (Qiagen) according to the manufacturer's protocol. Reverse transcription was performed using a QuantiTect^®^ Reverse Transcription kit (Qiagen), and quantitative real-time PCR (qRT-PCR) was performed using Maxima SYBR Green/ROX qPCR Master Mix (Thermo Fisher Scientific, Waltham, MA, USA), all according to the manufacturers' instructions. Samples were analyzed in triplicate for each gene, and the housekeeping gene of *β-actin* was used as a control gene. The expression level was evaluated by 2^−ΔΔCt^. The primers are listed in [Table 1](#t1-ijn-10-7057){ref-type="table"}.

Western blot
------------

Western blot analysis was performed according to the procedure previously described.[@b26-ijn-10-7057] The samples were harvested and washed with ice-cold phosphate-buffered saline followed by treatment with ice-cold radioimmunoprecipitation assay lysis buffer. Loading buffer was added, and the samples were boiled for 5 minutes. The proteins were loaded and run on 8%--12% sodium dodecyl sulfate--polyacrylamide gel electrophoresis. Subsequently, the proteins were transferred to polyvinylidene difluoride membranes (Millipore Corp, Atlanta, GA, USA). The membranes were blocked with 6% nonfat dry milk at room temperature for 1 hour before being incubated with the indicated primary antibodies overnight at 4°C, followed by horseradish peroxidase-conjugated secondary antibodies at room temperature for 1 hour. The blots were developed using enhanced chemiluminescence. The tested proteins included anti-SCP3 (Abcam, ab15093, Abcam, Cambridge, UK) and anti-actin (Abcam, ab8226, Abcam).

Statistical methods
-------------------

For each set of results, independent trials were repeated at least three times; the data are represented as means ± standard deviation. The differences among the means were statistically tested by Student's *t*-test or one-way analysis of variance followed by Tukey's test for multiple comparisons using Graph-Pad Prism analysis software (GraphPad Software, Inc., La Jolla, CA, USA). Comparisons were considered significant at *P*\<0.05 and *P*\<0.01.

Results and discussion
======================

Characterization of AgNPs
-------------------------

The AgNPs were synthesized using culture filtrate of *B. mycoides*. Synthesis of AgNPs using the biological method appears to be simple, cost-effective, and environmentally friendly. The as-prepared AgNPs were characterized using ultraviolet spectrophotometry, XRD, FT-IR, and TEM. The absorption spectra of the AgNPs were characteristic of highly symmetric single-band absorption, with a peak maxima at 426 nm ([Figure 1](#f1-ijn-10-7057){ref-type="fig"}), indicating excitation of surface plasmons typical for AgNPs. In addition, a strong broad peak was observed between 370 and 445 nm, indicating AgNP formation. Further characterization was performed to confirm the crystalline nature of the AgNPs. The XRD spectra for the AgNPs revealed three intense peaks over the entire spectrum of 2θ values, ranging from 10° to 80° ([Figure 2](#f2-ijn-10-7057){ref-type="fig"}). A comparison of our XRD spectra with the standard confirmed that the AgNPs formed in our experiments were nanocrystals, as evidenced by the peaks at 2θ values of 32.3°, 46.3°, 57.5°, and 77.0° corresponding to the (111), (200), (220), and (311) planes for silver, respectively ([Figure 2](#f2-ijn-10-7057){ref-type="fig"}). FT-IR spectra were used to identify the presence of biomolecules that could potentially contribute to the reduction of Ag^+^ ions or capping of the bioreduced AgNPs. As observed in [Figure 3](#f3-ijn-10-7057){ref-type="fig"}, the band at 1,389.10 cm^−1^ can be assigned to the C--N stretching vibrations of the aromatic and aliphatic amines. The FT-IR spectra of AgNPs synthesized from bacterial supernatant showed peaks at 3,434.78 and 1,628.34 cm^−1^, which are characteristic of the stretching modes for the O--H and C=O groups ([Figure 3](#f3-ijn-10-7057){ref-type="fig"}). AgNPs of different sizes exhibited similar spectra without any significant differences. The characterization of nanoparticles using TEM is a necessary step before assessing their in vitro toxicity.[@b52-ijn-10-7057] The physical and chemical properties of nanoparticles such as their particle size, size distribution, morphology, composition, surface area, surface chemistry, and reactivity in solution are important factors that are essential to assess nanoparticle toxicity.[@b52-ijn-10-7057] As seen in [Figure 4A](#f4-ijn-10-7057){ref-type="fig"}, the synthesized AgNPs were distributed uniformly and were spherical with a size of 4--24 nm, the average size was 8 nm. The mean size and standard deviation were calculated in random fields of various numbers of particles ([Figure 4B](#f4-ijn-10-7057){ref-type="fig"}).

Previous studies reported the use of a biological system for the synthesis of AgNPs using supernatant from *Bacillus licheniformis*[@b53-ijn-10-7057] and *Escherichia coli* cultures,[@b8-ijn-10-7057] in which the particles had an average size of 40 and 50 nm, respectively. Shankar et al[@b54-ijn-10-7057] produced AgNPs between 16 and 40 nm in size from geranium leaf extract. Mukherjee et al[@b55-ijn-10-7057] synthesized monodispersed spherical nanoparticles (20--60 nm) along with very few bigger particles (\~90 nm).[@b55-ijn-10-7057] Rodríguez-León et al[@b56-ijn-10-7057] synthesized two different populations of nanoparticles: one small in size with an average diameter around 3--5 nm and another larger in size, between 10 and 20 nm.[@b56-ijn-10-7057] Several fungi produce various sizes of AgNPs, including spent mushroom substrate, *Pleurotus florida*, *Volvariella volvacea*, and *Ganoderma neo-japonicum*, with an average size of 30.5, 20±5, 15, and 5 nm.[@b57-ijn-10-7057]--[@b60-ijn-10-7057] Together with these previous reports, our TEM data suggest that using a biological system can produce a defined and controlled size and that biomolecules stabilize AgNPs and prevent their aggregation, which are useful in several biomedical applications.

Maternal AgNPs exposure increased the meiotic progression of female germ cells in fetal mouse ovary
---------------------------------------------------------------------------------------------------

To investigate the effects of AgNPs on the meiotic progression of female germ cells within fetal ovaries after the exposure of pregnant mice to AgNPs, we prepared chromosome spreads from female fetal germ cell suspensions and immunostained them for the marker of meiotic prophase I, namely SCP3, a structural component of the axial and lateral parts of the synaptonemal complex. The results are presented in [Figure 5A and B](#f5-ijn-10-7057){ref-type="fig"}. At 17.5 dpc, the percentages of oocytes at the pachytene and diplotene stage in the treated group were 66.56% and 29.17%, respectively. In the control group, the percentages of oocytes at the pachytene and diplotene stage were 74.4% and 23.76%, respectively ([Figure 5C](#f5-ijn-10-7057){ref-type="fig"}). These results indicate that AgNP exposure promotes the progression of meiotic prophase I of oocytes.

To further confirm the effects of AgNPs on meiosis, quantitative RT-PCR and Western blotting were used to examine the expression of meiosis-specific genes at both the transcriptional and translational levels after AgNP exposure. As observed in [Figure 5D--E](#f5-ijn-10-7057){ref-type="fig"}, the relative mRNA expression levels of the meiosis-specific genes, *Stra8*, *Dazl*, *Scp1*, *Scp3*, and *Dmc1*, were increased significantly in the AgNP-treated groups compared with the control groups at 13.5 dpc ([Figure 5D](#f5-ijn-10-7057){ref-type="fig"}). In accordance with the expression of the transcription level, a similar protein expression pattern was observed in the SCP3 expression ([Figure 5E](#f5-ijn-10-7057){ref-type="fig"}).

BPA and diethylhexyl phthalate, two endocrine-disrupting chemicals, decreased the expression of meiosis gene *Stra8* by promoting DNA methylation and inhibited meiotic progression of female germ cells in fetal mouse ovary.[@b31-ijn-10-7057],[@b32-ijn-10-7057] After AgNP treatment, the expression of meiosis genes were upregulated: meiosis progression was promoted by AgNPs ([Figure 5](#f5-ijn-10-7057){ref-type="fig"}). Further studies are required to prove whether AgNPs could promote the development of the fetus.

Effect of AgNPs on various gene expressions of fetal ovaries
------------------------------------------------------------

To analyze the effects of AgNPs in pregnant mice, we investigated the mRNA expression of the development-related genes of oocytes ([Figure 6](#f6-ijn-10-7057){ref-type="fig"}). It is well known that the *Cx37* gene is thought to play a more critical role in ovarian function because the absence of either connexins causes a loss of oocyte--granulosa cell coupling and disruption of folliculogenesis.[@b61-ijn-10-7057],[@b62-ijn-10-7057] Zona pellucida (ZP) is an extracellular coating synthesized and secreted by the oocyte during follicular development and surrounds the plasma membrane of mammalian eggs and is involved in oogenesis.[@b63-ijn-10-7057],[@b64-ijn-10-7057] Several studies have suggested that growth differentiation factor 9 (*Gdf9*) and bone morphogenetic protein 15 (*Bmp15*) are required for early oocyte differentiation.[@b65-ijn-10-7057],[@b66-ijn-10-7057] Newborn ovary homeobox (*Nobox*), a homologous gene expression of a specific oocyte, is expressed in oocytes and plays an important role in oocyte survival and primordial follicle formation, which mutates, leading to the formation of syncytial follicles instead of primordial follicles.[@b67-ijn-10-7057],[@b68-ijn-10-7057] Factor in the germline alpha (*Figla*), an oocyte-specific basic helix-loop-helix transcription factor, plays critical dual roles in the activation of oocyte-associated genes and is required for primordial follicle formation and the expression of many genes required for folliculogenesis, fertilization, and early embryonic survival.[@b69-ijn-10-7057] As observed in [Figure 6](#f6-ijn-10-7057){ref-type="fig"}, after AgNP treatment, the relative mRNA levels of *Cx37*, ZP glycoprotein 1, 2, and 3 (*Zp1*, *Zp2*, and *Zp3*), and *Figla* genes were significantly reduced in the experimental group compared with those in the control group (*P*\<0.05). In addition, *Gdf9* and *Bmp15* expression decreased in the AgNP-treated group.

Aberrant expression of imprinted genes is associated with significant changes in total expression in placenta
-------------------------------------------------------------------------------------------------------------

To address whether the total expression of imprinted genes was affected by AgNP exposure, we analyzed the embryonic and placental tissues from the offspring of pregnant mice treated with and without AgNPs. We investigated the expression of the imprinted genes *H19* and *Zac1* in embryonic tissues ([Figure 7A](#f7-ijn-10-7057){ref-type="fig"}). RT-PCR analysis of *H19* and *Zac1* revealed that the mean total RNA of the embryos from mice exposed to AgNPs increased compared with that of the control embryos (1.09±0.04 versus 1.00±0.27 and 1.12±0.09 versus 1.00±0.11, respectively; n=15 in control group, n=14 in AgNPs-treated group; [Figure 7A](#f7-ijn-10-7057){ref-type="fig"}). In addition, we investigated the expression of eight imprinted genes, *Ascl2*, *Snrpn*, *Kcnq1ot1*, *Peg3*, *Zac1*, *H19*, *Igf2r*, and *Igf2*, relative to the reference gene *Gapdh* at 15.5 dpc. qRT-PCR analysis of the imprinted genes revealed that placentas from mice exposed to AgNPs showed a significant increase of mean total RNA compared with the control placentas. In female placentas, eight genes (*Ascl2*, *Snrpn*, *Kcnq1ot1*, *Peg3*, *Zac1*, *H19*, *Igf2r*, and *Igf2*) displayed changes in their expression patterns when the mother was treated with AgNPs. The expression of eight genes increased significantly in the AgNP-treated group compared with that of the control (*P*\<0.01, [Figure 7B](#f7-ijn-10-7057){ref-type="fig"}). A similar pattern was also observed in male placentas ([Figure S1](#SD1-ijn-10-7057){ref-type="supplementary-material"}).

Exposure of AgNPs disrupted the expression of imprinted genes in a tissue-specific manner ([Figure 7A and B](#f7-ijn-10-7057){ref-type="fig"}). Exposure of AgNPs resulted in significantly more placentas exhibiting a high expression of the paternally expressed *Snrpn* gene ([Figure 7B](#f7-ijn-10-7057){ref-type="fig"}). Loss of imprinting (LOI) occurred in placentas from AgNP-exposed mice compared with the control (*P*\<0.01; [Figure 7B](#f7-ijn-10-7057){ref-type="fig"}). Analysis of the placentas exhibiting LOI in the AgNP-treated group indicated that the normally repressed maternal *Snrpn* allele contributed a proportion of the total expression ([Figure 7B](#f7-ijn-10-7057){ref-type="fig"}). At the *Zac1* locus, AgNP exposure significantly resulted in LOI in the treated-group placentas compared with the controls ([Figure 7B](#f7-ijn-10-7057){ref-type="fig"}; *P*\<0.05), whereas no effects were observed in the embryos ([Figure 7A](#f7-ijn-10-7057){ref-type="fig"}). However, the same expression pattern was also observed in H19 of the embryos ([Figure 7A](#f7-ijn-10-7057){ref-type="fig"}).

Imprinted genes are dosage-sensitive. They encode proteins involved in common pathways and play multiple roles in the placenta, including regulation of the embryonic growth and transport capacity, thereby controlling the supply of nutrients to the fetus.[@b70-ijn-10-7057]--[@b73-ijn-10-7057] Placental expression profile of imprinted genes also impacts birth weight.[@b74-ijn-10-7057] Several lines of evidence have suggested that DNA methylation status can be altered by maternal diet.[@b75-ijn-10-7057] Maternal BPA exposure significantly disrupted imprinted gene expression in embryos and placentas, and the majority of affected genes were expressed abnormally in the placenta.[@b40-ijn-10-7057] Also, a high-fat diet during pregnancy modified the expression of imprinted genes and local and global DNA methylation patterns in the placenta.[@b39-ijn-10-7057] Sferruzzi-Perri et al[@b38-ijn-10-7057] also founded that feeding high-sugar and high-fat diets affected several growth regulatory imprinted genes (*Igf2*, *Dlk1*, *Snrpn*, *Grb10*, and *H19*) independently of changes in DNA methylation.

AgNP exposure alters average DNA methylation levels of the *Zac1* DMR and *Igf2r* DMR
-------------------------------------------------------------------------------------

To determine whether the LOI observed in the tissues from the AgNP-exposed mice was linked to abnormal patterns of DNA methylation, we performed DNA methylation analysis in 15.5 placentas. The *Zac1* imprint control element, which is a DMR containing 18CpG, plays a crucial role in regulating many imprinted genes in this cluster.[@b63-ijn-10-7057] We therefore investigated whether adaptation of the AgNP supply to fetal demand in pregnant mice involved the imprint control element/DMR regulating these important placental transporter systems. Pyrosequencing analysis of a subset of placentas (that of the *Zac1* gene) revealed a significant reduction in the mean methylation levels in AgNP-treated placentas (73.61%; n=9) compared with controls (48.75%; n=7; *P*\<0.01 through analysis of variance; [Figure 8](#f8-ijn-10-7057){ref-type="fig"}). However the methylation of *Igf2r* revealed a slight increase in the mean methylation levels in AgNP-treated placentas (52.7%; n=9) compared with the controls (45.5%; n=7; [Figure 9](#f9-ijn-10-7057){ref-type="fig"}). Three placentas from both control and AgNP exposure groups were analyzed by bisulfite sequencing, and the methylation status of ICR is shown in [Figures 8C](#f8-ijn-10-7057){ref-type="fig"} and [9C](#f9-ijn-10-7057){ref-type="fig"}.

*Zac1* and *Igf2r* genes are two important imprinted genes. Imprinted genes involved in the control of embryonic growth. *Zac1*, a member of coregulated gene, alters the expression of several of these imprinted genes, including *H19*, *Igf2*, *Cdkn1c*, and regulates the *Igf2/H19* locus through binding to a shared enhancer.[@b70-ijn-10-7057] *Igf2r* gene, a member insulin-like growth factor (IGF) system. Fetal growth is largely controlled by the complex IGF system.[@b75-ijn-10-7057] The expression of the *Zac1* and *Igf2r* genes are controlled by a germline differentially methylated regions. Upregulated expression of *Zac1* gene is correlated with the downregulation of methylation of Zac1 ([Figure 8](#f8-ijn-10-7057){ref-type="fig"}). But there was only a slight increase in the mean methylation of the *Igf2r* DMR ([Figure 9](#f9-ijn-10-7057){ref-type="fig"}). Our findings suggest that upregulation of *Igf2r* genes is independent of imprinting mechanisms. Some studies have shown that the altered expression was not associated with imprinting dysregulation or LOI.[@b76-ijn-10-7057] Further detailed studies are warranted to determine the effects and precise role of AgNPs on the embryonic growth.

Conclusion
==========

This study describes the synthesis of a controlled size of AgNPs using a biological system, which is simple, convenient, cost-effective, and environmentally friendly. We prepared smaller AgNPs with an average size of 8 nm and investigated the effect of the AgNPs in pregnant mice. The results indicated that the AgNPs disturbed the first meiosis progression and expression of imprinted genes in placental tissue. In addition, the epigenetic methylation was affected, the methylation of *Zac1* gene was significantly reduced in AgNP-treated placentas, and the mean methylation of *Igf2r* revealed a slight increase in AgNP-treated group. These changes in placental gene expression could potentially explain the accelerated fetal growth observed during the third trimester. Upregulation of maternally expressed imprinted genes induces primordial germ cells to prematurely stop proliferation and enter into meiotic prophase. This study could facilitate the production of nanoparticles with improved biocompatibility and the creation of safer nanomaterials.

Supplementary material
======================

###### 

Samples from the control and AgNP-treated group placentas on the male mouse at 15.5 dpc were analyzed for total expression of the imprinted genes.

**Notes:** The relative mRNA expression of the imprinted genes (*Ascl2*, *Snrpn*, *Kcnq1ot1*, *Peg3*, *Zac1*, *H19*, *Igf2r*, and *Igf2*) in placentas (n=8 in control group; n=7 in AgNPs-treated group). The results are presented as means ± SD. \**P*\<0.05; \*\**P*\<0.01.

**Abbreviations:** AgNPs, silver nanoparticles; SD, standard deviation; dpc, days postcoitum; mRNA, messenger RNA.
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![The absorption spectrum of AgNPs synthesized by *Bacillus mycoides* culture supernatant.\
**Note:** The absorption spectrum of AgNPs exhibited a strong broad peak at 426 nm, which is assigned to surface plasmon resonance of the particle.\
**Abbreviations:** AgNPs, silver nanoparticles; au, arbitrary unit.](ijn-10-7057Fig1){#f1-ijn-10-7057}

![XRD spectra of AgNPs.\
**Note:** There are three intense peaks across the spectrum of 2θ values ranging from 10° to 80°.\
**Abbreviations:** XRD, X-ray diffraction; AgNPs, silver nanoparticles; au, arbitrary unit.](ijn-10-7057Fig2){#f2-ijn-10-7057}

![FT-IR spectra of AgNPs.\
**Abbreviations:** FT-IR, Fourier transform infrared; AgNPs, silver nanoparticles.](ijn-10-7057Fig3){#f3-ijn-10-7057}

![TEM images of AgNPs.\
**Notes:** (**A**) TEM images of several fields were used to measure the AgNP particle size; micrograph (**B**) size distributions based on TEM images of AgNPs ranging from 4 to 24 nm.\
**Abbreviations:** TEM, transmission electron microscopy; AgNPs, silver nanoparticles; au, arbitrary unit.](ijn-10-7057Fig4){#f4-ijn-10-7057}

![Effects of AgNPs on progress of meiosis prophase I.\
**Notes:** (**A**) The characteristics of chromosomes in oocytes at meiosis I stained with SCP3 antibody (red) and Hoechst33342 (blue). (**B**) The percentage of fetal mouse oocytes at different phases of meiosis prophase I with or without exposure of pregnant mice to DEHP at 13.5 dpc. (**C**) The percentage of fetal mouse oocytes at different phases of meiosis prophase I with or without the exposure of pregnant mice to DEHP at 17.5 dpc. (**D**) The relative mRNA expression of meiosis-specific genes, including *Stra8*, *Dazl*, *Scp1*, *Scp3*, and *Dmc1* at 13.5 dpc in the ovaries of fetal mice with or without maternal AgNPs exposure. Each sample for RNA extraction contains four ovaries, and the expression of these genes was normalized to *β-actin*. (**E**) The relative protein expression of *Scp3* gene at 13.5 dpc in the ovaries of fetal mice with or without maternal AgNPs exposure. Every three ovaries were harvested at 13.5 dpc. All the experiments were repeated at least three times. The results are presented as means ± SD. \**P*\<0.05; \*\**P*\<0.01.\
**Abbreviations:** AgNPs, silver nanoparticles; DEHP, diethylhexyl phthalate; dpc, days postcoitum; SD, standard deviation; mRNA, messenger RNA; SCP, synaptonemal complex protein.](ijn-10-7057Fig5){#f5-ijn-10-7057}

![AgNP exposure altered total mRNA expression of the development-related genes of oocytes.\
**Notes:** Relative mRNA levels of genes related to the development of oocytes at 15.5 dpc. n=15 in control group; n=14 in AgNPs-treated group. All of the experiments were repeated at least three times. The results are presented as means ± SD. \**P*\<0.05; \*\**P*\<0.01.\
**Abbreviations:** AgNPs, silver nanoparticles; dpc, days postcoitum; mRNA, messenger RNA.](ijn-10-7057Fig6){#f6-ijn-10-7057}

![AgNP exposure altered total mRNA expression of imprinted genes relative to reference genes in embryos and placentas of female mouse at 15.5 dpc.\
**Notes:** (**A**) Relative mRNA expression of *H19* and *Zac1* genes in embryos (n=15 in control group; n=14 in AgNPs-treated group). (**B**) Relative mRNA expression of imprinted genes (*Ascl2*, *Snrpn*, *Kcnq1ot1*, *Peg3*, *Zac1*, *H19*, *Igf2r*, and *Igf2*) in placentas (n=8 in control group; n=7 in AgNP-treated group). The results are presented as means ± SD. \**P*\<0.05; \*\**P*\<0.01.\
**Abbreviations:** AgNPs, silver nanoparticles; SD, standard deviation; dpc, days postcoitum; mRNA, messenger RNA.](ijn-10-7057Fig7){#f7-ijn-10-7057}

![Analysis of control and AgNP-exposed placentas indicated that exposure significantly reduced methylation of *Zac1* gene.\
**Notes:** The *Zac1* DMRs are depicted in (**A**), including the sequences analyzed in the (**B**) pyrosequencing and (**C**) bisulfite sequencing assays. (**A**) In total, 18 CpG sites (highlighted in red) located in a 383 bp region of the *Zac1* DMR were assayed by bisulfite sequencing. The 18 CpGs were analyzed by pyrosequencing. (**B**) Pyrosequencing data in control and AgNPs exposure are shown with samples exhibiting black circles of *Zac1*. The *y*-axis represents the percentage of total methylation. The black horizontal line in each exposure group indicates the average methylation. The sample sizes analyzed in each exposure group are indicated; *P*\<0.01 when analyzed using one-way ANOVA. The results are presented as means ± SD. \*\**P*\<0.01. (**C**) Three placentas from both the control and AgNP exposure groups were analyzed by bisulfite sequencing, and the methylation status of *Zac1* is shown. The CpG sites within DMRs are shown; filled squares denote methylated and open squares denote unmethylated. The percentages of methylation at all the CpGs are indicated. The average CpG methylation levels are 72.82% in the control group and 50.07% in the AgNPs-treated group (*P*\<0.01).\
**Abbreviations:** AgNPs, silver nanoparticles; DMR, DNA methylated region; ANOVA, analysis of variance.](ijn-10-7057Fig8){#f8-ijn-10-7057}

![Analysis of control and AgNP-exposed placentas indicated that exposure increased methylation of the *Igf2r* gene.\
**Notes:** The *Igf2r* DMRs are depicted in (**A**), including the sequences analyzed in the (**B**) pyrosequencing and (**C**) bisulfite sequencing assays. (**A**) In total, 30 CpG sites (highlighted in red) located in a 490 bp region of the *Igf2r* DMR were assayed by bisulfite sequencing. The 30 CpGs were analyzed by pyrosequencing. (**B**) Pyrosequencing data for the control and AgNPs exposure are presented with the samples exhibiting black circles of *Igf2r*. The *y*-axis represents the percentage of total methylation. The black horizontal line in each exposure group indicates the average methylation. The sample sizes analyzed in each exposure group are indicated. (**C**) Three placentas from both the control and AgNP exposure groups were analyzed by bisulfite sequencing, and the methylation status of *Igf2r* is indicated. The CpG sites within DMRs are shown; filled squares denote methylated and open squares denote unmethylated. The percentages of methylation at all CpGs are indicated. The average CpG methylation levels are 45.5% in the control group and 52.7% in the AgNPs-treated group (*P*\<0.01).\
**Abbreviations:** AgNPs, silver nanoparticles; DMR, DNA methylated region.](ijn-10-7057Fig9){#f9-ijn-10-7057}

###### 

Primers used for quantitative RT-PCR

  Genes        Sequences of primers                 GenBank
  ------------ ------------------------------------ ---------------
  *GAPDH*      F: 5′-AGGTCGGTGTGAACGGATTTG-3′       NC_000072.6
               R: 5′-TGTAGACCATGTAGTTGAGGTCA-3′     
  *Stra8*      F: 5′-CTCCTCCTCCACTCTGTTGC-3′        XM_004046 273
               R: 5′-GCGGCAGAGACAATAGGAAG-3′        
  *Dazl*       F: 5′-TGACGTGGATGTGCAGAAGAT-3′       NM_010021
               R: 5′-AGGAGGATATGCCTGAACATACT-3′     
  *Scp1*       F: 5′-AGAAGCAAAAGCCCTTCACACT-3′      NC_000069
               R: 5′-ACCTTTATCAATGTTTTCCCGACT-3′    
  *Scp3*       F: 5′-CCGCTGAGCAAACATCTAAAG-3′       NC_000076
               R: 5′-ATCAGCAACATCTTCTTCTGAACC-3′    
  *Dmc1*       F: 5′-CCCTCTGTGTGACAGCTCAAC-3′       NM_010059
               R: 5′-GGTCAGCAATGTCCCGAAG-3′         
  *Cx37*       F: 5′-GTCAGCGTGCTGTGTAAGAGTG-3′      NC_000070.6
               R: 5′-GCAGGTTGAGCACCAGGGAGATGAC-3′   
  *Cx43*       F: 5′-TGTGGGCAAGACACGAATATG-3′       NC_000076.6
               R: 5′-GACAAGGTCCAAGCCTACTCCC-3′      
  *Gdf9*       F: 5′-CTGATAGGCGAGGTGAGACC-3′        NC_000077.6
               R: 5′-GAGCCGGACGGTATTGTAGA-3′        
  *Bmp15*      F: 5′-TTCTTAGAATTCTTTTGTGGGGAGT-3′   NC_000086.7
               R: 5′-TGGTATAACTTGAGCATGTACCTCA-3′   
  *Zp1*        F: 5′-GTCCGACTCCTGCAGAGAAC-3′        NC_000085.6
               R: 5′-TGATGGTGAAGCGCTGATAG-3′        
  *Zp2*        F: 5′-AAGGTCTTGAGCAGGAACGA-3′        NC_000073.6
               R: 5′-GGGTGGAAAGTAGTGCGGTA-3′        
  *Zp3*        F: 5′-CCGAGCTGTGCAATTCCCAGA-3′       NC_000071.6
               R: 5′-AACCCTCTGAGCCAAGGGTGA-3′       
  *Nobox*      F: 5′-CTATCCTGACAGTGACAAACGCC-3′     NC_000072.6
               R: 5′-CACCCTCTCAGCACCCTCATTAT-3′     
  *Figla*      F: 5′-ACAGAGCAGGAAGCCCAGTA-3′        NC_000072.6
               R: 5′-TGGGTAGCATTTCCCAAGAG-3′        
  *Bax*        F: 5′-ATGCGTCCACCAAGAAGCTGAG-3′      NC_000073.6
               R: 5′-CCCCAGTTGAAGTTGCCATCAG-3′      
  *Bcl2*       F: 5′-ACTGAATGTAGATAATGG-3′          NC_000067.6
               R: 5′-TAACTGTAACTGATAAGG-3′          
  *Caspase3*   F: 5′-GATAATGTCTTAGAACTTGAATCC-3′    NC_000074.6
               R: 5′-CTTCCATAAATCAGGTCCAA-3′        
  *Ascl2*      F: 5′-TGAGCATCCCACCCCCCTA-3′         NC_000073.6
               R: 5′-CCAAACATCAGCGTCAGTATAG-3′      
  *Snrpn*      F: 5′-CTGCAGCACATTGACTATAGGATG-3′    NC_000073
               R: 5′-ACAGTCATTGAAACCAAGTTCTCC-3′    
  *Kcnq1ot1*   F: 5′-TCCATGGTGAGGTCTTATCTTGTT-3′    NC_000073.6
               R: 5′-GAAAAGAAGCGTGTTGAAGAAAAA-3′    
  *Peg3*       F: 5′-AAGGCTCTGGTTGACAGTCGTG-3′      NC_000073.6
               R: 5′-TTCTCCTTGGTCTCACGGGC-3′        
  *Zac1*       F: 5′-TCACCATTCACAATTATTCCCACT-3′    NC_000076
               R: 5′-CTTCCGGTTGAATGTCTTCTCAC-3′     
  *H19*        F: 5′-ACCCCGGGATGACTTCATC-3′         NC_000073.6
               R: 5′-TATCTCCGGGACTCCAAACC-3′        
  *Igf2r*      F: 5′-TTACACATGGGAAGCTGTTGACT-3′     NC_000083.6
               R: 5′-CGGCAGTTCTCTGTCTTTAGGTC-3′     
  *Igf2*       F: 5′-GGGGAGCTATGGGTAGGAAG-3′        NC_000073.6
               R: 5′-GGCATAAAATTTGGGGTCCT-3′        

**Abbreviation:** RT-PCR, real-time polymerase chain reaction.
